Title : Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.

Pub. Date : 2017 Aug

PMID : 28781650






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The present study investigated whether this urothelium-specific recombinant adenovirus (Ad5-UPII-E1A) enhanced mitomycin (MMC) and hydroxycamptothecin (HCPT) sensitization and drug-induced apoptosis in bladder cancer cells. Mitomycin uroplakin 2 Homo sapiens
2 The present study investigated whether this urothelium-specific recombinant adenovirus (Ad5-UPII-E1A) enhanced mitomycin (MMC) and hydroxycamptothecin (HCPT) sensitization and drug-induced apoptosis in bladder cancer cells. Mitomycin uroplakin 2 Homo sapiens
3 Treatment with MMC or HCPT enhanced Ad5-UPII-E1A-induced apoptosis in 5,637 cells, observed by transmission electron microscopy. Mitomycin uroplakin 2 Homo sapiens
4 Western blot analysis revealed that MMC and HCPT enhanced the E1A expression of the Ad5-UPII-E1A vectorin a dose-dependent manner. Mitomycin uroplakin 2 Homo sapiens
5 The present study demonstrated that Ad5-UPII-E1A combined with MMC or HCPT resulted in synergistic cytotoxicity in a process which involved the promotion of apoptosis in bladder cancer cell lines. Mitomycin uroplakin 2 Homo sapiens
6 MMC and HCPT also promoted the oncolytic effect of Ad5-UPII-E1A. Mitomycin uroplakin 2 Homo sapiens